CONTINUUM The ASAM CRITERIA Decision Engine TM

Similar documents
Questions Asked During the Live Webinar Broadcast on 3/14/12

Are We Ready for ASAM? Does the ASAM Level of Care Designa:ons Correspond to Clinical Judgment?

Assessment. Clinical Steps To ensuring the needs Of your clients are Identified

What is Treatment Planning? Clinical Evaluation: Treatment Planning Goals and Objectives

ASAM CRITERIA 3 rd Edition

DSM-5 AND ASAM CRITERIA. Presented by Jaime Goffin, LCSW

SUD Requirements. Proprietary

ADULT Addictions Treatment: Medically Monitored Residential Treatment (3B)

ASAM Criteria What it is and Why it s Important

Addiction Assessment and the ASAM PPC-2R

Adult 65D-30 Intervention ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA

DMHAS ASAM SERVICE DESCRIPTIONS

Referral to Treatment: Utilizing the ASAM Criteria

Chapter 7. Screening and Assessment

What Using The ASAM Criteria Really Means: Skill-Building and Systems Change. David Mee-Lee, M.D.

Evidence based Practices

Chapter 7. Screening and Assessment

IMPLEMENTING RECOVERY ORIENTED CLINICAL SERVICES IN OPIOID TREATMENT PROGRAMS PILOT UPDATE. A Clinical Quality Improvement Program

American Addiction Centers Outcomes Study Long-Term Outcomes Among Residential Addiction Treatment Clients. Centerstone Research Institute

ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines

ASAM Level.05 DIMENSIONS Circle all items in each dimension that apply to the client. ADMISSION CRITERIA

ASAM Criteria, Third Edition Matrix for Matching Adult Severity and Level of Function with Type and Intensity of Service

Psychosocial Treatments for Opioid Use Disorder Overview

CSAT s Knowledge Application Program. KAP Keys. For Clinicians

Outpatient Treatment, Psychiatric and Substance Use Disorders, Rehabilitation

Understanding and Using Current ASAM Criteria. for Ce-Classes.com

Evidence-Based Practice: Psychosocial Interventions

AMBULATORY WITHDRAWAL MANAGEMENT

Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form Initial Requests ASAM Levels 2.1/2.5/3.1/3.3/3.5/3.7/4.

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS

TOOL 1: QUESTIONS BY ASAM DIMENSIONS

VIRGINIA MEDICAID PERSPECTIVE ON BEST PRACTICES IN THE TREATMENT OF OPIOID USE DISORDER

OUTPATIENT TREATMENT WESTPORT, CONNECTICUT

WHY THE ASI SHOULD BE REPLACED AND WHY MANDATES FOR ITS USE SHOULD BE ELIMINATED

California Institute for Behavioral Health Solutions. Drug Medi-Cal Organized Delivery System (DMC-ODS) Waiver Training Project

The New ASAM Criteria: Implications for Drug Courts

Behavioral Health Prior Authorization Form

Centerstone Research Institute

Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form Initial Requests ASAM Levels 2.1/2.5/3.1/3.3/3.5/3.7/4.

Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form ASAM Levels 2.1/2.5/3.1/3.5/3.7/4.0

Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form ASAM Levels 2.1/2.5/3.1/3.5/3.7/4.0

5/30/2018. Assessment and Treatment Planning for Substance Use Disorder. Learning Objectives. Introductions

BEHAVIORAL H E A L T H T R E A T M E N T. for a bright future

A bridge too far? CTN vs. non-ctn program comparisons and implications for innovation adoption

Exploring Barriers & Solutions in Facilitating Detox

Clinical Evaluation: Assessment Goals

6/6/2018. Objectives. Outline. Rethinking Medication Treatment for Opioid Use Disorder

Substance Abuse Level of Care Criteria

2017 ADDICTION PROGRAM PACKAGE

McLean Ambulatory Treatment Center Adult Partial Hospital and Residential Program for Alcohol and Drug Abuse 115 Mill Street Belmont, MA 02478

GUIDANCE FOR APPLICATION OF ASAM IN PENNSYLVANIA S SUBSTANCE USE DISORDER (SUD) SYSTEM OF CARE May 2018

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

How Profit Status Makes a Difference in the Delivery of Substance Abuse Treatment Services

The ASAM Criteria Introduction. [ June 2017]

Medication Supported Recovery- A Review of Evidence-Based Practice

IDDT Fidelity Action Planning Guidelines

An Alternative Payment Model Concept for Office-based Treatment of Opioid Use Disorder

John F. Kelly, Ph.D. The Role of AA in Mobilizing Adaptive Social Network Changes: A Prospective Lagged Mediational Analysis

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

California Institute for Behavioral Health Solutions. Drug Medi-Cal Organized Delivery System (DMC-ODS) Waiver Training Project

ULTIMATE GUIDE TO SOBER LIVING HOUSES

The Treatment of Illicit Drug Taking

Treatment Team Approaches in Substance Abuse Treatment

Clinical UM Guideline. This document provides medical necessity criteria for levels of care relating to substance and addictive disorders.

Clinical UM Guideline

PERSPECTIVE FROM VIRGINIA: SUCCESS ADDRESSING THE OPIOID CRISIS THROUGH MEDICAID ADDICTION AND RECOVERY TREATMENT SERVICES (ARTS)

Integrated Care Model for Problem Gambling

ROSC & MAT II: Opioid Treatment Services

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Medical Necessity Criteria 2017

Rapid Recovery Referral The Warm Handoff. Charles F. Barbera, MD, MBA, FACEP, FAAEM Chairman Department of Emergency Medicine

Closing the Loop in Treating Opioid Addiction:

2/19/18. Today s talk. Today s talk. The Role of Behavioral Interventions in Buprenorphine Treatment of Opioid Use Disorders

CACREP Competency Areas on iwebfolio

SBIRT for Education & Faith-Based Settings Geneva Sanford, MSW, LSW, LICDC-CS

Improving Outcomes in Methadone Treatment

Extended-Release Naltrexone for Opioid Relapse Prevention

The science of the mind: investigating mental health Treating addiction

A MULTI-LAYERED APPROACH TO RECOVERY: VETERAN AND MILITARY FAMILY CASE EXAMPLES

The Importance of Psychological Treatment and Behavioral Support

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder

In 2008, an estimated 282,000 persons

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Main Results and Clinical Implications of the X:BOT Trial: XR-Naltrexone vs. Buprenorphine-Naloxone Film

Treatment and the Recovery Process. Treatment Options. Treatment Options. Hagedorn MHS

Final Evaluation Report

Addiction and Recovery Treatment Services (ARTS) Service Authorization Review Form Extension Requests ASAM Levels 2.1/2.5/3.1/3.3/3.5/3.7/4.

Screening, Brief Interventions, Referrals to Treatment: Use of SBIRT in Practice

Treatment Works, Kentucky: An Overview of Substance Abuse Treatment Outcomes from KTOS

Adult Mental Health Services applicable to Members in the State of Connecticut subject to state law SB1160

Literature Review: Substance Abuse Outpatient Treatment Services. Authors: Miriam Verploegh, PhD Institute for Social Research.

Alberta Alcohol and Drug Abuse Commission. POSITION ON ADDICTION AND MENTAL HEALTH February 2007

Service Review Criteria

DUI SERVICE PROVIDER ORIENTATION

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

addiction clear haven center

Lessons learned from 15 years of NIH funded 12 step Mechanisms of Behavior Change Research: Implications for treatment and recovery

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

Extended-Release Naltrexone for Opioid Relapse Prevention Among Community Criminal Justice Participants

Effective Management of Substance Use Disorder Patients in an Emergency Department Setting

Transcription:

A National Standard for Addiction Treatment Planning and Utilization Review: CONTINUUM The ASAM CRITERIA Decision Engine TM David R. Gastfriend MD Chief Architect, CONTINUUM TM

Disclosure of Relevant Financial Relationships Name Commercial Interests Relevant Financial Relationships: What Was Received Relevant Financial Relationships: For What Role No Relevant Financial Relationships with Any Commercial Interests David Gastfriend Recovery Search, Inc Royalty Pres. & CEO Alkermes, Inc Stock Former VP, Sci. Communications

Addiction assessment: A sorry state of affairs Non-standard, intuitive, then find out the rest later Managed Care wants more data: Telephone tag (90 min 3 days) Most insurers medical necessity criteria are Proprietary Absent precision & validity, emphasis is on cost, not quality 1991: ASAM Patient Placement Criteria a teaching tool States create their own Criteria (CASAM, MASAM, NYSAM, ) ASAM in Major US MCO: ~50% of cases were denials on appeal: ~50% reversed; on review ~50% reversed again! By 2000s, SAMHSA & CSAT called on ASAM for a standard

Advances in Treatment Matching Modality Matching: many studies, e.g., Project MATCH but few findings (Gastfriend & McLellan, Med Clin NA, 1997) Placement Matching: Multiple studies; ASAM model consistent signals (Gastfriend, Addiction Treatment Matching, Haworth Press, 2004) Support: NIDA: Validation - R01-DA08781 & K24-DA00427 NIAAA: PPC-2R Assessment Software - SBIR grant R44-AA12004 CSAT: Access to Recovery Initiative - grant 270-02-7120 Belgian National Fund for Scientific Research Belgian American Educational Foundation Central Norway Health Trust /Rusbehandling Midt-Norge SAMHSA: Open Behavioral Health IT Architecture Program

ASAM text: hundreds of decision rules To place patients in the least intensive & restrictive care that meets the patient s multi-dimensional needs and affords optimal treatment outcome www.haworthpress.com www.asamcriteria.org

ASAM Patient Placement Criteria Screening Diagnosis Severity Readiness & Relapse Potential Patient Placement Criteria DIMENSIONS 1 2 3 Intoxication Biomedical Emotional Withdrawal Behavioral 4 5 6 Treatment Relapse Recovery Acceptance/ Potential Environment Resistance Decision Rules LEVEL OF CARE 1. Outpatient 2. Intensive Outpatient 3. Medically Monitored Intensive Inpatient 4. Medically Managed Intensive Inpatient

ASAM PLACEMENT CRITERIA LEVELS OF 1. OUTPT 2. INTENSIVE 3. MED 4. MED OF CARE OUTPT MON INPT MGD INPT CRITERIA Intoxication/ Withdrawal no risk minimal some risk severe risk medical 24-hr acute monitoring med. care required required Medical Complications no risk manageable Psych/Behav Complications no risk mild severity moderate cooperative high resist., Readiness but requires needs 24-hr For Change cooperative structure motivating Relapse Potential Recovery Environment maintains abstinence supportive more symptoms, needs close monitoring less support, w/ structure can cope unable to control use in outpt care danger to recovery, logistical incapacity for outpt 24-hr psych. & addiction Tx required

ASAM PPC Decision Rules Mr. D. Mr. D. is a 41 y/o MWM unemployed carpenter, referred by his wife, a nurse, who, after a recent relapse, will soon throw him out if he continues his daily 6-pack habit and Percocet. His history includes no prior withdrawal symptoms, but + major depression with suicidal ideation, intermittent prescribed opiates for low back injury, & alcoholism in his father. He would now accept treatment, including abstinence from any opiates, restarting his antidepressant, & attending some AA meetings.

ASAM PPC Decision Rules Mr. D. LEVEL OF CARE D I M E N S I O N 1 2 3 4 5 6 WD Bio Psy Mot Rel Env 4 - Med Mgd - - - 3 - Med Mon - - + - - - 2 - Day Tx 1 - Outpatient + + - - - - + + - + + + Level 2

ASAM PLACEMENT CRITERIA Dimension 1.Intox/WD 2.Biomedical 3.Emot l/behav l Levels: Out- Opioid Day Residential Hospital patient Treatment Treatment Rehabilitation (Medically Program Partial Hosp. Managed) 0.5 1 OTP 2.1, 2.5 3.1, 3.3, 3.5, 3.7 4 Sub-levels: Withdrawal Management (L-1, 2.5, 3.2, 3.7, 4) Biomedical Enhanced (L-3.7) Co-Occurring Disorders Capable (L-2, 3) Co-Occurring Disorders Enhanced (L-2, 3) 4.Readiness 5. Relapse Potential 6.Environment

MGH-Harvard ASAM Criteria Validity Study Gastfriend, et al. Supported by NIDA grants # R01-DA08781 & K24-DA00427 Randomized controlled trial (RCT) in 3 Cities in Eastern MA Tested matched v. mismatched assignments with PPC-1 Compared Levels II (IOP) & III (Residential) Outcomes: No-show to step-down care Balanced for gender, ethnicity (N=700) Used computerized algorithm with blinded raters, patients & treaters Based on instruments with known reliability B.A. level interviewers achieved inter-rater reliability of 0.77 (ICC)

Percent No-Shows to Next Treatment Under-Matching Worsens No Show to Next Treatment 70% From Inpatient Detox to Either Residential Rehab or Day Treatment: All patients, High Frequency Cocaine Users and Heroin Users p.001 60% 50% 40% p.019 Under-matched patients no-show rate: ~25% worse Under-matched patients no-show rate: ~100% worse p.001 30% 20% 10% Under-matched patients no-show rate: ~300% worse 0% All Patients (N=700) Cocaine (N=183) Heroin (N=279) Mis-matched Matched

ASAM in Patients with + Comorbid Symptoms (Angarita et al., JAM 2007) Supported by NIDA grants # R01-DA08781 & K24-DA00427

Percent No-shows ASAM in Patients with + Comorbid Symptoms (Angarita et al., JAM 2007) No-show rates: Comorbids vs. Non-Comorbids, by Matching Status 80 70 60 71.2 61.7 54.3 58.5 Comorbids Non-Comorbids 54* 50 40 30 37.5 32.9 28* ~90% worse 20 10 0 Under-matched to IOP but needs Resid l Matched to IOP Matching Status Matched to Residential Over-matched to Resid l but needs IOP *P < 0.01

PPC-2R Validity at 1-Month in Belgium (Ansseau et al., unpublished) Programs in 4 LOCs, naturalistically rated 201 subjects Recruited in equal proportions from the 4 LOCs Assessed by trained psychologists Outcomes: 1 month, 5-point global rating scale Assessors, patients, programs, & raters all blind Results: Adequate matches (n = 140) were significantly better than mismatches (n = 27) (p<0.05)

ASAM-PPC 1 Validity at 3 Months in NYC (Magura et al., Am J Add n 2003) Supported by NIAAA grant R01-AA10863

Drinking Days in Past 30 Alcohol use by naturalistic Levels of Care & mismatching (N=219) 10 9 8 7 6 5 4 3 2 1 0 * Clinician-Rated * Algorithm-Rated Matched Undertreated

Bed-Day Utilization over 1-Yr in the VA (Sharon et al., JAD 2003) Supported by NIDA grants # R01-DA08781 & K24-DA00427

Annualized Bed-Days Bed-day Use Pre- vs. Post-Naturalistic L-III Placements 35 ~24-mos Before 30 ~13 mos After * 25 20 15 10 5 0 Adequate (II) Matched (III) Lesser LOC (IV)

Predictive Validity: The Norwegian Study Stallvik M, Gastfriend DR, Nordahl HM Funded by the Central Norway Health Trust Prospective, double-blind, multi-site (n=10) naturalistic design N= 261, naturalistically placed by counselors across 3 counties Baseline (BL) interview & 3 mo. follow-up (F/U) Independent raters used ASAM Criteria Software 2nd Ed.-Rev. Outcomes at 3 Month Follow-Up: 1) Dropout 2) Drug use frequency 3) ASI Composite Score Changes 4) Recommended level of care at F/U

3-mo Drop-Out, Improvement & Stepdown Need 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% % Drop Out at 3-Mo F/U Under- Matched 7 6 5 4 3 2 1 0 # ASI Subscales Improved at F/U Under- Matched Over- Over- 70% 60% 50% 40% 30% 20% 10% 0% % of Patients Ready for Stepdown at F/U (vs. BL) Stepdown Same LOC Higher LOC Under- Matched Over- Naturalistic Match Status According to ASAM Software

Conclusions The ASAM Criteria Software decision rules show face validity Technology provides good reliability & feasibility Comparison to other instruments shows good concurrent validity Predictive validity overall & with heroin, cocaine & comorbidity Valid for undermatching, AND for overmatching Predictive validity: in multiple cultures/systems: public/va; MA/NYC; Belgium/Norway at multiple time-frames: immediate, 30-d, 90-d & 1-year with multiple outcomes: no-show, global improvement, substance use, step-down readiness, rehospitalization

Stakeholders in the Health IT Revolution Client Researcher Counselor Employer/ Payer Society Supervisor Managed Care Accreditation Body, Government System

ASAM Criteria Health Services Research National Treatment Center Study - 450 programs (U. of GA) >70% of respondents using ASAM Criteria by 1996 Single-level programs: 34% - 42% less likely than multi-levels (p<.01) Dual diagnosis capable programs: 3.4 times more likely to adopt (p.01) Programs closing within 24 mos. were less likely to be ASAM adopters in 1996 (p<.05) Programs closing within 6 mos. even lower baseline adoption

Case Study: CRC Health Operates 145 sites treating 30,000 people Largest behavioral health provider in U.S. Devotes significant resources to payer approval Each center has 3-5 FTEs dedicated to UR ~20% of cases are contested by payers ~30% of MD time is lost interacting w/payers If this administrative time is reduced only slightly, the ASAM Software could yield substantial savings. Also, CRC recognizes the benefits that increased reliance on health IT could provide. HARVARD BUSINESS SCHOOL

Beta Testing: Milwaukee County N= 7 counselors, daily use over 6 months in Central Intake Units overwhelmingly positive, very user friendly already use ASAM & ASI, but not as consolidated or organized as the software & the report a big plus from the Central Intake Staff no challenges in the learning curve very easy to use very comparable duration (~2 hrs) vs. the prior approach; the Software does not add to the time a deeper look into the patient & what s going on Milwaukee County therefore would like to expand use to the County-wide system (~30 Intake Counselors), Plus they would like ASAM to develop modules for Recovery Support Services & Mental Health intakes.

Clinical Decision Support: Output DSM-IV and DSM-5 Substance Use Disorders: Diagnoses & Criteria CIWA-Ar & CINA withdrawal scores (alcohol/bzs, opioids) Addiction Severity Index (ASI) Composite Scores Imminent Risk Considerations Access & Support Needs/Capabilities ASAM Level of Care recommendations Including Withdrawal Management Including Biomedically Enhanced Sub-level Including Co-occurring Disorder Sub-levels (Capable, Enhanced) Also: If actual placement disagrees with Software, the clinician gets to justify the discrepancy

Addiction assessment: A new, state-of-the-art standard THE PAST Non-standard, intuitive Telephone tag Proprietary criteria Emphasis on cost, not quality 1991: ASAM a teaching tool Each state creates its own Criteria Managed Care Study: ~50% of cases reversed By 2000s, SAMHSA wants a standard NOW Standardized, quantitative Rapid Prior Authorization Public domain criteria Emphasis on cost AND quality 2015: ASAM a decision tool A single national standard for Criteria Managed care: Willing to pilot AUTOMATIC prior authorization 2015, SAMHSA has a standard